These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3964529)

  • 1. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins.
    Park BK; Choonara IA; Haynes BP; Breckenridge AM; Malia RG; Preston FE
    Br J Clin Pharmacol; 1986 Mar; 21(3):289-93. PubMed ID: 3964529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit.
    Park BK; Leck JB
    Biochem Pharmacol; 1982 Nov; 31(22):3635-9. PubMed ID: 7181945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.
    Breckenridge AM; Cholerton S; Hart JA; Park BK; Scott AK
    Br J Pharmacol; 1985 Jan; 84(1):81-91. PubMed ID: 3978316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioavailability of a mixed micellar preparation of vitamin K1, and its procoagulant effect in anticoagulated rabbits.
    Winn MJ; White PM; Scott AK; Pratt SK; Park BK
    J Pharm Pharmacol; 1989 Apr; 41(4):257-60. PubMed ID: 2568466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of factors which determine the pharmacological response to vitamin K in coumarin anticoagulated rabbits.
    Hart JA; Haynes BP; Park BK
    Biochem Pharmacol; 1984 Oct; 33(19):3013-9. PubMed ID: 6487353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.
    Choonara IA; Scott AK; Haynes BP; Cholerton S; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1985 Dec; 20(6):643-8. PubMed ID: 4091996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case management and plasma half-life in a case of brodifacoum poisoning.
    Hollinger BR; Pastoor TP
    Arch Intern Med; 1993 Aug; 153(16):1925-8. PubMed ID: 8250654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired deficiency of vitamin K-dependent clotting factors due to brodifacoum ingestion.
    Kapadia P; Bona R
    Conn Med; 2008 Apr; 72(4):207-9. PubMed ID: 18478986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.
    Feinstein DL; Nosal DG; Ramanathan S; Zhou J; Chen L; Hershow RC; van Breemen RB; Wright E; Hafner JW; Rubinstein I
    Clin Toxicol (Phila); 2020 Jul; 58(7):716-724. PubMed ID: 31736367
    [No Abstract]   [Full Text] [Related]  

  • 11. Symptomatic brodifacoum ingestion requiring high-dose phytonadione therapy.
    Sheen SR; Spiller HA; Grossman D
    Vet Hum Toxicol; 1994 Jun; 36(3):216-7. PubMed ID: 8066968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K1 metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats.
    Leck JB; Park BK
    Biochem Pharmacol; 1981 Jan; 30(2):123-8. PubMed ID: 7236301
    [No Abstract]   [Full Text] [Related]  

  • 13. An investigation of the pharmacological response to vitamin K1 in the rabbit.
    Winn MJ; Cholerton S; Park BK
    Br J Pharmacol; 1988 Aug; 94(4):1077-84. PubMed ID: 3207975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiomers of warfarin and vitamin K1 metabolism.
    Choonara IA; Haynes BP; Cholerton S; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1986 Dec; 22(6):729-32. PubMed ID: 3567019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy.
    Tsutaoka BT; Miller M; Fung SM; Patel MM; Olson KR
    Pharmacotherapy; 2003 Sep; 23(9):1186-9. PubMed ID: 14524650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covert poisoning with difenacoum: clinical and toxicological observations.
    McCarthy PT; Cox AD; Harrington DJ; Evely RS; Hampton E; al-Sabah AI; Massey E; Jackson H; Ferguson T
    Hum Exp Toxicol; 1997 Mar; 16(3):166-70. PubMed ID: 9088970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemorrhagic syndrome caused by exposure to a rodenticide. Report of a case].
    Vásquez A; Rodríguez MA
    Rev Med Chil; 2000 Jun; 128(6):647-9. PubMed ID: 11016065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.
    Choonara IA; Malia RG; Haynes BP; Hay CR; Cholerton S; Breckenridge AM; Preston FE; Park BK
    Br J Clin Pharmacol; 1988 Jan; 25(1):1-7. PubMed ID: 3370190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.
    Shearer MJ; Bechtold H; Andrassy K; Koderisch J; McCarthy PT; Trenk D; Jähnchen E; Ritz E
    J Clin Pharmacol; 1988 Jan; 28(1):88-95. PubMed ID: 3350995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of sex-linked differences to the toxic and to the pharmacological actions of difenacoum: studies in mice and rats.
    Winn MJ; Clegg JA; Park BK
    J Pharm Pharmacol; 1987 Mar; 39(3):219-22. PubMed ID: 2883288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.